BioCentury
DATA GRAPHICS | Product Development

Point’s SPAC, Aktis’ A round add to cash flow for radiotherapies: Data Byte

March 19, 2021 12:59 AM UTC

A SPAC for Point Biopharma Inc. and a series A round for Aktis Oncology Inc., both announced this week, add to the recent wave of investment in targeted radiotherapies.

On Monday, Point announced a merger with a SPAC sponsored by RA Capital Management to form  Point Biopharma Global Inc. (NASDAQ:PNT). The company, which raised a $20 million series A round last August, expects to receive about $300 million through the deal. ...